Physician profile
Anthony Wayne Alexander
NPI 1396745485
$9,753.27
in general payments reported to CMS, 2019-2025
15 companies · $1,958 in 2025
The $1,958 reported for 2025 was more than what 93% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $126 · 2021: $74.91 · 2022: $115 · 2023: $3,763 · 2024: $3,472 · 2025: $1,958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,998 · Food and Beverage: $2,194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,998.40 |
| Food and Beverage | $2,194.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,234.45 | 2023-2024 | Venaseal, Abre, Intellis Adaptivestim |
| Bard Peripheral Vascular, INC. | $1,298.84 | 2025 | Venclose Maven Catheter |
| Forte Bio-Pharma LLC | $988.39 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Boston Scientific Corporation | $868.52 | 2022-2024 | Varithena Administration Pack |
| Medtronic Vascular, INC. | $86.75 | 2019 | |
| Novo Nordisk INC | $67.13 | 2019-2021 | |
| Abbott Laboratories | $47.55 | 2019 | |
| Dexcom, INC. | $32.25 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.40 | 2021-2023 | Xarelto |
| Gilead Sciences, INC. | $22.84 | 2023 | |
| Abbvie INC. | $19.53 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $19.52 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.30 | 2019 | |
| Glaxosmithkline, LLC. | $13.06 | 2019 | |
| Kaleo, INC. | $11.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.